BHT Imaging Based Cancer Instant Detector from Advanced Bioresearch

The Center of Bioholography in Georgia and the Advanced Bioresearch & Technology Ltd (ABR) have developed the Cancer Instant Detector (CID) device that is based on the low-cost Bioholo-tomography (BHT) imaging technology.

This technique does not expose the patient or the doctor to ionizing radiation. BHT technology is able to acquire holographic information related to any affected part of the human body for diagnostic purposes by using surface readings only.

The likelihood of cancer, its degree of effectiveness, and its location in a pre-defined part of the body can be found out and displayed in seconds by utilizing the CID detection tool. The imaging technique has proved considerable validity and dependability for controlled clinical study and every day practice. The device can be used for evaluating treated patients, mass screening and tracking at-risk patients worldwide.

Technologies, such as bioholo-tomography, based on complete human body evaluation can help speed up the exploration of the cancer targeting therapies as it can be less time consuming or expensive to develop and test new drugs. A new kind of information related to the human body’s information is possible through this technology that records and analyzes biological holograms.

Frost & Sullivan’s latest research has reported that this new cancer diagnostics technique can target a particular region or organ of interest, and enable the capture and analysis of high resolution images.

Cancer detection at its earliest possible phases is the best strategy to enhance the quality of life of cancer patients reducing cancer deaths. However, most of the cancers in the early development phases do not have noticeable symptoms and may not be possible to detect unless the patient reports for a check-up at the office of the physician or cancer screening schemes.

Georgia-based Center of Bioholography’s Founder Dr. Marina Shaduri informed that the non-invasive technique using a CID lasts a mere few minutes. It is harmless for operators, patients as well as the environment.

Prasanna Vadhana Kannan, Research Analyst at Technical Insights Group of Frost & Sullivan that has been monitoring the technology’s developments since 2005 revealed that the CID consists of a portable and simplified gadget that has the ability to gather diagnostic quality information for revealing physiological anomalies.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.